Shiratori, Souichi
Okada, Kohei
Sugita, Junichi
Nishida, Mutsumi
Iwai, Takahito
Ota, Shuichi
Hashimoto, Daigo
Teshima, Takanori
Article History
Received: 7 December 2022
Accepted: 28 September 2023
First Online: 13 October 2023
Competing interests
: SS, KO, TI, SO and DH have no conflict of interest to declare. JS reports honoraria from Pfizer and scholarship donation from Kyowa Kirin, MN reports grant from NIPPON SHINYAKU, and TT reports grant from Chugai, Kyowa Kirin, Sanofi, Astellas, TEIJIN PHARMA, Novartis, Fuji Pharma, and NIPPON SHINYAKU, honoraria from Merck Sharp & Dohme, Takeda, Kyowa Kirin, Bristol-Myers Squibb, and Pfizer, leadership or fiduciary role from Merck Sharp & Dohme, Takeda, and Novartis, and other financial interests from Janssen and Novartis, during the conduct of the study.